Toronto, Ontario–(Newsfile Corp. – March 9, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company”) wholly-owned subsidiary, Sairiyo Therapeutics Inc. (“Sairiyo”), a biotechnology company focused on the research and development of Cepharanthine, a repurposed and reformulated naturally-derived compound for the potential treatment of cancer, neurological…


Previous articlePT234 – Christopher Solomon – Salvia as a Therapist
Next articleCybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition